Guardian Wealth Advisors (North Carolina)’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$404 Buy
+2
New +$414 ﹤0.01% 604
2025
Q3
Sell
-2
Closed -$325 404
2025
Q2
$325 Hold
2
﹤0.01% 544
2025
Q1
$343 Hold
2
﹤0.01% 523
2024
Q4
$335 Hold
2
﹤0.01% 505
2024
Q3
$344 Hold
2
﹤0.01% 443
2024
Q2
$308 Hold
2
﹤0.01% 431
2024
Q1
$308 Hold
2
﹤0.01% 447
2023
Q4
$316 Hold
2
﹤0.01% 433
2023
Q3
$293 Sell
2
-36
-95% -$5.49K ﹤0.01% 414
2023
Q2
$5.82K Hold
38
﹤0.01% 357
2023
Q1
$5.89K Hold
38
﹤0.01% 355
2022
Q4
$5.86K Sell
38
-2
-5% -$295 ﹤0.01% 330
2022
Q3
$5K Hold
40
﹤0.01% 308
2022
Q2
$5K Sell
40
-1
-2% -$138 ﹤0.01% 310
2022
Q1
$6K Sell
41
-3,343
-99% -$495K ﹤0.01% 222
2021
Q4
$548K Buy
+3,384
New +$547K 0.24% 80

Other funds holding FBT

Guardian Wealth Advisors (North Carolina)'s FBT Position: Q1 2026 in Review

Guardian Wealth Advisors (North Carolina) opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026: 2 shares worth $404. The stake represents ﹤0.01% of the portfolio and ranks #604 among its holdings. This is a return to the name: Guardian Wealth Advisors (North Carolina) previously reported a position in FBT as recently as Q2 2025.

Guardian Wealth Advisors (North Carolina) first reported a position in FBT in Q4 2021 and has held it in 16 quarters since. The position peaked at $548K in Q4 2021. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Guardian Wealth Advisors (North Carolina) held 2 shares of First Trust NYSE Arca Biotechnology Index Fund worth $404 as of Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Guardian Wealth Advisors (North Carolina) position in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q1 2026, its #604 holding.
  • Guardian Wealth Advisors (North Carolina) first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and has held it in 16 quarters since.
  • Guardian Wealth Advisors (North Carolina)'s First Trust NYSE Arca Biotechnology Index Fund position peaked at $548K in Q4 2021.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 15 May 2026.